1 Study Coverage 1.1 Nuclear Receptor ROR-Gamma Product Introduction 1.2 Market Segments 1.3 Key Nuclear Receptor ROR-Gamma Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Type 1.4.2 VPR-66 1.4.3 INV-17 1.4.4 GSK-2981278 1.4.5 BBI-6000 1.4.6 Others 1.5 Market by Application 1.5.1 Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Application 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Nuclear Receptor ROR-Gamma Market Size, Estimates and Forecasts 2.1.1 Global Nuclear Receptor ROR-Gamma Revenue 2015-2026 2.1.2 Global Nuclear Receptor ROR-Gamma Sales 2015-2026 2.2 Global Nuclear Receptor ROR-Gamma, Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.3 Nuclear Receptor ROR-Gamma Historical Market Size by Region (2015-2020) 2.3.1 Global Nuclear Receptor ROR-Gamma Retrospective Market Scenario in Sales by Region: 2015-2020 2.3.2 Global Nuclear Receptor ROR-Gamma Retrospective Market Scenario in Revenue by Region: 2015-2020 2.4 Nuclear Receptor ROR-Gamma Market Estimates and Projections by Region (2021-2026) 2.4.1 Global Nuclear Receptor ROR-Gamma Sales Forecast by Region (2021-2026) 2.4.2 Global Nuclear Receptor ROR-Gamma Revenue Forecast by Region (2021-2026) 3 Global Nuclear Receptor ROR-Gamma Competitor Landscape by Players 3.1 Global Top Nuclear Receptor ROR-Gamma Sales by Manufacturers 3.1.1 Global Nuclear Receptor ROR-Gamma Sales by Manufacturers (2015-2020) 3.1.2 Global Nuclear Receptor ROR-Gamma Sales Market Share by Manufacturers (2015-2020) 3.2 Global Nuclear Receptor ROR-Gamma Manufacturers by Revenue 3.2.1 Global Nuclear Receptor ROR-Gamma Revenue by Manufacturers (2015-2020) 3.2.2 Global Nuclear Receptor ROR-Gamma Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Nuclear Receptor ROR-Gamma Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Nuclear Receptor ROR-Gamma Revenue in 2019 3.2.5 Global Nuclear Receptor ROR-Gamma Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Nuclear Receptor ROR-Gamma Price by Manufacturers 3.4 Global Nuclear Receptor ROR-Gamma Manufacturing Base Distribution, Product Types 3.4.1 Nuclear Receptor ROR-Gamma Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Nuclear Receptor ROR-Gamma Product Type 3.4.3 Date of International Manufacturers Enter into Nuclear Receptor ROR-Gamma Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Nuclear Receptor ROR-Gamma Market Size by Type (2015-2020) 4.1.1 Global Nuclear Receptor ROR-Gamma Sales by Type (2015-2020) 4.1.2 Global Nuclear Receptor ROR-Gamma Revenue by Type (2015-2020) 4.1.3 Nuclear Receptor ROR-Gamma Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Nuclear Receptor ROR-Gamma Market Size Forecast by Type (2021-2026) 4.2.1 Global Nuclear Receptor ROR-Gamma Sales Forecast by Type (2021-2026) 4.2.2 Global Nuclear Receptor ROR-Gamma Revenue Forecast by Type (2021-2026) 4.2.3 Nuclear Receptor ROR-Gamma Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Nuclear Receptor ROR-Gamma Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2026) 5.1 Global Nuclear Receptor ROR-Gamma Market Size by Application (2015-2020) 5.1.1 Global Nuclear Receptor ROR-Gamma Sales by Application (2015-2020) 5.1.2 Global Nuclear Receptor ROR-Gamma Revenue by Application (2015-2020) 5.1.3 Nuclear Receptor ROR-Gamma Price by Application (2015-2020) 5.2 Nuclear Receptor ROR-Gamma Market Size Forecast by Application (2021-2026) 5.2.1 Global Nuclear Receptor ROR-Gamma Sales Forecast by Application (2021-2026) 5.2.2 Global Nuclear Receptor ROR-Gamma Revenue Forecast by Application (2021-2026) 5.2.3 Global Nuclear Receptor ROR-Gamma Price Forecast by Application (2021-2026) 6 United States by Players, Type and Application 6.1 United States Nuclear Receptor ROR-Gamma Market Size YoY Growth 2015-2026 6.1.1 United States Nuclear Receptor ROR-Gamma Sales YoY Growth 2015-2026 6.1.2 United States Nuclear Receptor ROR-Gamma Revenue YoY Growth 2015-2026 6.1.3 United States Nuclear Receptor ROR-Gamma Market Share in Global Market 2015-2026 6.2 United States Nuclear Receptor ROR-Gamma Market Size by Players (International and Local Players) 6.2.1 United States Top Nuclear Receptor ROR-Gamma Players by Sales (2015-2020) 6.2.2 United States Top Nuclear Receptor ROR-Gamma Players by Revenue (2015-2020) 6.3 United States Nuclear Receptor ROR-Gamma Historic Market Review by Type (2015-2020) 6.3.1 United States Nuclear Receptor ROR-Gamma Sales Market Share by Type (2015-2020) 6.3.2 United States Nuclear Receptor ROR-Gamma Revenue Market Share by Type (2015-2020) 6.3.3 United States Nuclear Receptor ROR-Gamma Price by Type (2015-2020) 6.4 United States Nuclear Receptor ROR-Gamma Market Estimates and Forecasts by Type (2021-2026) 6.4.1 United States Nuclear Receptor ROR-Gamma Sales Forecast by Type (2021-2026) 6.4.2 United States Nuclear Receptor ROR-Gamma Revenue Forecast by Type (2021-2026) 6.4.3 United States Nuclear Receptor ROR-Gamma Price Forecast by Type (2021-2026) 6.5 United States Nuclear Receptor ROR-Gamma Historic Market Review by Application (2015-2020) 6.5.1 United States Nuclear Receptor ROR-Gamma Sales Market Share by Application (2015-2020) 6.5.2 United States Nuclear Receptor ROR-Gamma Revenue Market Share by Application (2015-2020) 6.5.3 United States Nuclear Receptor ROR-Gamma Price by Application (2015-2020) 6.6 United States Nuclear Receptor ROR-Gamma Market Estimates and Forecasts by Application (2021-2026) 6.6.1 United States Nuclear Receptor ROR-Gamma Sales Forecast by Application (2021-2026) 6.6.2 United States Nuclear Receptor ROR-Gamma Revenue Forecast by Application (2021-2026) 6.6.3 United States Nuclear Receptor ROR-Gamma Price Forecast by Application (2021-2026) 7 North America 7.1 North America Nuclear Receptor ROR-Gamma Market Size YoY Growth 2015-2026 7.2 North America Nuclear Receptor ROR-Gamma Market Facts & Figures by Country 7.2.1 North America Nuclear Receptor ROR-Gamma Sales by Country (2015-2020) 7.2.2 North America Nuclear Receptor ROR-Gamma Revenue by Country (2015-2020) 7.2.3 U.S. 7.2.4 Canada 8 Europe 8.1 Europe Nuclear Receptor ROR-Gamma Market Size YoY Growth 2015-2026 8.2 Europe Nuclear Receptor ROR-Gamma Market Facts & Figures by Country 8.2.1 Europe Nuclear Receptor ROR-Gamma Sales by Country 8.2.2 Europe Nuclear Receptor ROR-Gamma Revenue by Country 8.2.3 Germany 8.2.4 France 8.2.5 U.K. 8.2.6 Italy 8.2.7 Russia 9 Asia Pacific 9.1 Asia Pacific Nuclear Receptor ROR-Gamma Market Size YoY Growth 2015-2026 9.2 Asia Pacific Nuclear Receptor ROR-Gamma Market Facts & Figures by Country 9.2.1 Asia Pacific Nuclear Receptor ROR-Gamma Sales by Region (2015-2020) 9.2.2 Asia Pacific Nuclear Receptor ROR-Gamma Revenue by Region 9.2.3 China 9.2.4 Japan 9.2.5 South Korea 9.2.6 India 9.2.7 Australia 9.2.8 Taiwan 9.2.9 Indonesia 9.2.10 Thailand 9.2.11 Malaysia 9.2.12 Philippines 9.2.13 Vietnam 10 Latin America 10.1 Latin America Nuclear Receptor ROR-Gamma Market Size YoY Growth 2015-2026 10.2 Latin America Nuclear Receptor ROR-Gamma Market Facts & Figures by Country 10.2.1 Latin America Nuclear Receptor ROR-Gamma Sales by Country 10.2.2 Latin America Nuclear Receptor ROR-Gamma Revenue by Country 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Nuclear Receptor ROR-Gamma Market Size YoY Growth 2015-2026 11.2 Middle East and Africa Nuclear Receptor ROR-Gamma Market Facts & Figures by Country 11.2.1 Middle East and Africa Nuclear Receptor ROR-Gamma Sales by Country 11.2.2 Middle East and Africa Nuclear Receptor ROR-Gamma Revenue by Country 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 4SC AG 12.1.1 4SC AG Corporation Information 12.1.2 4SC AG Description and Business Overview 12.1.3 4SC AG Sales, Revenue and Gross Margin (2015-2020) 12.1.4 4SC AG Nuclear Receptor ROR-Gamma Products Offered 12.1.5 4SC AG Recent Development 12.2 Advinus Therapeutics Ltd. 12.2.1 Advinus Therapeutics Ltd. Corporation Information 12.2.2 Advinus Therapeutics Ltd. Description and Business Overview 12.2.3 Advinus Therapeutics Ltd. Sales, Revenue and Gross Margin (2015-2020) 12.2.4 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Products Offered 12.2.5 Advinus Therapeutics Ltd. Recent Development 12.3 Arrien Pharmaceuticals, LLC 12.3.1 Arrien Pharmaceuticals, LLC Corporation Information 12.3.2 Arrien Pharmaceuticals, LLC Description and Business Overview 12.3.3 Arrien Pharmaceuticals, LLC Sales, Revenue and Gross Margin (2015-2020) 12.3.4 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Products Offered 12.3.5 Arrien Pharmaceuticals, LLC Recent Development 12.4 Aurigene Discovery Technologies Limited 12.4.1 Aurigene Discovery Technologies Limited Corporation Information 12.4.2 Aurigene Discovery Technologies Limited Description and Business Overview 12.4.3 Aurigene Discovery Technologies Limited Sales, Revenue and Gross Margin (2015-2020) 12.4.4 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Products Offered 12.4.5 Aurigene Discovery Technologies Limited Recent Development 12.5 Biogen, Inc. 12.5.1 Biogen, Inc. Corporation Information 12.5.2 Biogen, Inc. Description and Business Overview 12.5.3 Biogen, Inc. Sales, Revenue and Gross Margin (2015-2020) 12.5.4 Biogen, Inc. Nuclear Receptor ROR-Gamma Products Offered 12.5.5 Biogen, Inc. Recent Development 12.6 Brickell Biotech, Inc. 12.6.1 Brickell Biotech, Inc. Corporation Information 12.6.2 Brickell Biotech, Inc. Description and Business Overview 12.6.3 Brickell Biotech, Inc. Sales, Revenue and Gross Margin (2015-2020) 12.6.4 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Products Offered 12.6.5 Brickell Biotech, Inc. Recent Development 12.7 Bristol-Myers Squibb Company 12.7.1 Bristol-Myers Squibb Company Corporation Information 12.7.2 Bristol-Myers Squibb Company Description and Business Overview 12.7.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020) 12.7.4 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Products Offered 12.7.5 Bristol-Myers Squibb Company Recent Development 12.8 Celgene Corporation 12.8.1 Celgene Corporation Corporation Information 12.8.2 Celgene Corporation Description and Business Overview 12.8.3 Celgene Corporation Sales, Revenue and Gross Margin (2015-2020) 12.8.4 Celgene Corporation Nuclear Receptor ROR-Gamma Products Offered 12.8.5 Celgene Corporation Recent Development 12.9 Genentech, Inc. 12.9.1 Genentech, Inc. Corporation Information 12.9.2 Genentech, Inc. Description and Business Overview 12.9.3 Genentech, Inc. Sales, Revenue and Gross Margin (2015-2020) 12.9.4 Genentech, Inc. Nuclear Receptor ROR-Gamma Products Offered 12.9.5 Genentech, Inc. Recent Development 12.10 Genfit SA 12.10.1 Genfit SA Corporation Information 12.10.2 Genfit SA Description and Business Overview 12.10.3 Genfit SA Sales, Revenue and Gross Margin (2015-2020) 12.10.4 Genfit SA Nuclear Receptor ROR-Gamma Products Offered 12.10.5 Genfit SA Recent Development 12.11 4SC AG 12.11.1 4SC AG Corporation Information 12.11.2 4SC AG Description and Business Overview 12.11.3 4SC AG Sales, Revenue and Gross Margin (2015-2020) 12.11.4 4SC AG Nuclear Receptor ROR-Gamma Products Offered 12.11.5 4SC AG Recent Development 12.12 Hanmi Pharmaceuticals, Co. Ltd. 12.12.1 Hanmi Pharmaceuticals, Co. Ltd. Corporation Information 12.12.2 Hanmi Pharmaceuticals, Co. Ltd. Description and Business Overview 12.12.3 Hanmi Pharmaceuticals, Co. Ltd. Sales, Revenue and Gross Margin (2015-2020) 12.12.4 Hanmi Pharmaceuticals, Co. Ltd. Products Offered 12.12.5 Hanmi Pharmaceuticals, Co. Ltd. Recent Development 12.13 Karo Bio AB 12.13.1 Karo Bio AB Corporation Information 12.13.2 Karo Bio AB Description and Business Overview 12.13.3 Karo Bio AB Sales, Revenue and Gross Margin (2015-2020) 12.13.4 Karo Bio AB Products Offered 12.13.5 Karo Bio AB Recent Development 12.14 Lead Pharma Holding B.V. 12.14.1 Lead Pharma Holding B.V. Corporation Information 12.14.2 Lead Pharma Holding B.V. Description and Business Overview 12.14.3 Lead Pharma Holding B.V. Sales, Revenue and Gross Margin (2015-2020) 12.14.4 Lead Pharma Holding B.V. Products Offered 12.14.5 Lead Pharma Holding B.V. Recent Development 12.15 Nuevolution AB 12.15.1 Nuevolution AB Corporation Information 12.15.2 Nuevolution AB Description and Business Overview 12.15.3 Nuevolution AB Sales, Revenue and Gross Margin (2015-2020) 12.15.4 Nuevolution AB Products Offered 12.15.5 Nuevolution AB Recent Development 12.16 Phenex Pharmaceuticals AG 12.16.1 Phenex Pharmaceuticals AG Corporation Information 12.16.2 Phenex Pharmaceuticals AG Description and Business Overview 12.16.3 Phenex Pharmaceuticals AG Sales, Revenue and Gross Margin (2015-2020) 12.16.4 Phenex Pharmaceuticals AG Products Offered 12.16.5 Phenex Pharmaceuticals AG Recent Development 12.17 Reata Pharmaceuticals, Inc. 12.17.1 Reata Pharmaceuticals, Inc. Corporation Information 12.17.2 Reata Pharmaceuticals, Inc. Description and Business Overview 12.17.3 Reata Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020) 12.17.4 Reata Pharmaceuticals, Inc. Products Offered 12.17.5 Reata Pharmaceuticals, Inc. Recent Development 12.18 Teijin Pharma Limited 12.18.1 Teijin Pharma Limited Corporation Information 12.18.2 Teijin Pharma Limited Description and Business Overview 12.18.3 Teijin Pharma Limited Sales, Revenue and Gross Margin (2015-2020) 12.18.4 Teijin Pharma Limited Products Offered 12.18.5 Teijin Pharma Limited Recent Development 12.19 Visionary Pharmaceuticals, Inc. 12.19.1 Visionary Pharmaceuticals, Inc. Corporation Information 12.19.2 Visionary Pharmaceuticals, Inc. Description and Business Overview 12.19.3 Visionary Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020) 12.19.4 Visionary Pharmaceuticals, Inc. Products Offered 12.19.5 Visionary Pharmaceuticals, Inc. Recent Development 12.20 Vitae Pharmaceuticals, Inc. 12.20.1 Vitae Pharmaceuticals, Inc. Corporation Information 12.20.2 Vitae Pharmaceuticals, Inc. Description and Business Overview 12.20.3 Vitae Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020) 12.20.4 Vitae Pharmaceuticals, Inc. Products Offered 12.20.5 Vitae Pharmaceuticals, Inc. Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter’s Five Forces Analysis 13.5 Primary Interviews with Key Nuclear Receptor ROR-Gamma Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Nuclear Receptor ROR-Gamma Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Nuclear Receptor ROR-Gamma Market Segments Table 2. Ranking of Global Top Nuclear Receptor ROR-Gamma Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million) Table 4. Major Manufacturers of VPR-66 Table 5. Major Manufacturers of INV-17 Table 6. Major Manufacturers of GSK-2981278 Table 7. Major Manufacturers of BBI-6000 Table 8. Major Manufacturers of Others Table 9. Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Application 2020-2026 (K Pcs) Table 10. Global Nuclear Receptor ROR-Gamma Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026 Table 11. Global Nuclear Receptor ROR-Gamma Sales by Regions 2015-2020 (K Pcs) Table 12. Global Nuclear Receptor ROR-Gamma Sales Market Share by Regions (2015-2020) Table 13. Global Nuclear Receptor ROR-Gamma Revenue by Regions 2015-2020 (US$ Million) Table 14. Global Nuclear Receptor ROR-Gamma Sales Forecast by Region (2021-2026) (K Pcs) Table 15. Global Nuclear Receptor ROR-Gamma Sales by Manufacturers (2015-2020) (K Pcs) Table 16. Global Nuclear Receptor ROR-Gamma Sales Share by Manufacturers (2015-2020) Table 17. Global Nuclear Receptor ROR-Gamma Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 18. Global Nuclear Receptor ROR-Gamma by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Receptor ROR-Gamma as of 2019) Table 19. Nuclear Receptor ROR-Gamma Revenue by Manufacturers (2015-2020) (US$ Million) Table 20. Nuclear Receptor ROR-Gamma Revenue Share by Manufacturers (2015-2020) Table 21. Key Manufacturers Nuclear Receptor ROR-Gamma Price (2015-2020) (USD/Pcs) Table 22. Nuclear Receptor ROR-Gamma Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Nuclear Receptor ROR-Gamma Product Type Table 24. Date of International Manufacturers Enter into Nuclear Receptor ROR-Gamma Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Nuclear Receptor ROR-Gamma Sales by Type (2015-2020) (K Pcs) Table 27. Global Nuclear Receptor ROR-Gamma Sales Share by Type (2015-2020) Table 28. Global Nuclear Receptor ROR-Gamma Revenue by Type (2015-2020) (US$ Million) Table 29. Global Nuclear Receptor ROR-Gamma Revenue Share by Type (2015-2020) Table 30. Nuclear Receptor ROR-Gamma Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs) Table 31. Global Nuclear Receptor ROR-Gamma Sales Share by Type (2021-2026) Table 32. Global Nuclear Receptor ROR-Gamma Sales by Application (2015-2020) (K Pcs) Table 33. Global Nuclear Receptor ROR-Gamma Sales Share by Application (2015-2020) Table 34. Global Nuclear Receptor ROR-Gamma Sales Share by Application (2021-2026) Table 35. Global Nuclear Receptor ROR-Gamma Sales Market Share Forecast by Application (2021-2026) Table 36. Global Nuclear Receptor ROR-Gamma Revenue by Application (2015-2020) (US$ Million) Table 37. Global Nuclear Receptor ROR-Gamma Revenue Market Share Forecast by Application (2021-2026) Table 38. United States Nuclear Receptor ROR-Gamma Sales (K Pcs) of Key Companies (2015-2020) Table 39. United States Nuclear Receptor ROR-Gamma Sales Share by Company (2015-2020) Table 40. United States Nuclear Receptor ROR-Gamma Revenue (US$ Million) by Company (2015-2020) Table 41. United States Nuclear Receptor ROR-Gamma Sales (K Pcs) by Type (2015-2020) Table 42. United States Nuclear Receptor ROR-Gamma Sales Share by Type (2015-2020) Table 43. United States Nuclear Receptor ROR-Gamma Revenue (US$ Million) Market Share by Type (2015-2020) Table 44. United States Nuclear Receptor ROR-Gamma Price (K Pcs) by Type (2015-2020) Table 45. United States Nuclear Receptor ROR-Gamma Sales (K Pcs) by Type (2021-2026) Table 46. United States Nuclear Receptor ROR-Gamma Sales Share by Type (2021-2026) Table 47. United States Nuclear Receptor ROR-Gamma Revenue (US$ Million) Market Share by Type (2021-2026) Table 48. United States Nuclear Receptor ROR-Gamma Revenue Share by Type (2021-2026) Table 49. United States Nuclear Receptor ROR-Gamma Price (K Pcs) by Type (2021-2026) Table 50. United States Nuclear Receptor ROR-Gamma Sales (K Pcs) by Application (2015-2020) Table 51. United States Nuclear Receptor ROR-Gamma Sales Share by Application (2015-2020) Table 52. United States Nuclear Receptor ROR-Gamma Revenue (US$ Million) Market Share by Application (2015-2020) Table 53. United States Nuclear Receptor ROR-Gamma Sales (K Pcs) by Application (2021-2026) Table 54. United States Nuclear Receptor ROR-Gamma Sales Share by Application (2021-2026) Table 55. United States Nuclear Receptor ROR-Gamma Revenue (US$ Million) Market Share by Application (2021-2026) Table 56. United States Nuclear Receptor ROR-Gamma Revenue Share by Application (2021-2026) Table 57. North America Nuclear Receptor ROR-Gamma Sales by Country (2015-2020) (K Pcs) Table 58. North America Nuclear Receptor ROR-Gamma Sales Market Share by Country (2015-2020) Table 59. North America Nuclear Receptor ROR-Gamma Revenue by Country (2015-2020) (US$ Million) Table 60. North America Nuclear Receptor ROR-Gamma Revenue Market Share by Country (2015-2020) Table 61. Europe Nuclear Receptor ROR-Gamma Sales by Country (2015-2020) (K Pcs) Table 62. Europe Nuclear Receptor ROR-Gamma Sales Market Share by Country (2015-2020) Table 63. Europe Nuclear Receptor ROR-Gamma Revenue by Country (2015-2020) (US$ Million) Table 64. Europe Nuclear Receptor ROR-Gamma Revenue Market Share by Country (2015-2020) Table 65. Asia Pacific Nuclear Receptor ROR-Gamma Sales by Region (2015-2020) (K Pcs) Table 66. Asia Pacific Nuclear Receptor ROR-Gamma Sales Market Share by Region (2015-2020) Table 67. Asia Pacific Nuclear Receptor ROR-Gamma Revenue by Region (2015-2020) (US$ Million) Table 68. Asia Pacific Nuclear Receptor ROR-Gamma Revenue Market Share by Region (2015-2020) Table 69. Latin America Nuclear Receptor ROR-Gamma Sales by Country (2015-2020) (K Pcs) Table 70. Latin America Nuclear Receptor ROR-Gamma Sales Market Share by Country (2015-2020) Table 71. Latin Americaa Nuclear Receptor ROR-Gamma Revenue by Country (2015-2020) (US$ Million) Table 72. Latin America Nuclear Receptor ROR-Gamma Revenue Market Share by Country (2015-2020) Table 73. Middle East and Africa Nuclear Receptor ROR-Gamma Sales by Country (2015-2020) (K Pcs) Table 74. Middle East and Africa Nuclear Receptor ROR-Gamma Sales Market Share by Country (2015-2020) Table 75. Middle East and Africa Nuclear Receptor ROR-Gamma Revenue by Country (2015-2020) (US$ Million) Table 76. Middle East and Africa Nuclear Receptor ROR-Gamma Revenue Market Share by Country (2015-2020) Table 77. 4SC AG Corporation Information Table 78. 4SC AG Description and Business Overview Table 79. 4SC AG Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 80. 4SC AG Nuclear Receptor ROR-Gamma Product Table 81. 4SC AG Recent Development Table 82. Advinus Therapeutics Ltd. Corporation Information Table 83. Advinus Therapeutics Ltd. Description and Business Overview Table 84. Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 85. Advinus Therapeutics Ltd. Product Table 86. Advinus Therapeutics Ltd. Recent Development Table 87. Arrien Pharmaceuticals, LLC Corporation Information Table 88. Arrien Pharmaceuticals, LLC Description and Business Overview Table 89. Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 90. Arrien Pharmaceuticals, LLC Product Table 91. Arrien Pharmaceuticals, LLC Recent Development Table 92. Aurigene Discovery Technologies Limited Corporation Information Table 93. Aurigene Discovery Technologies Limited Description and Business Overview Table 94. Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 95. Aurigene Discovery Technologies Limited Product Table 96. Aurigene Discovery Technologies Limited Recent Development Table 97. Biogen, Inc. Corporation Information Table 98. Biogen, Inc. Description and Business Overview Table 99. Biogen, Inc. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 100. Biogen, Inc. Product Table 101. Biogen, Inc. Recent Development Table 102. Brickell Biotech, Inc. Corporation Information Table 103. Brickell Biotech, Inc. Description and Business Overview Table 104. Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 105. Brickell Biotech, Inc. Product Table 106. Brickell Biotech, Inc. Recent Development Table 107. Bristol-Myers Squibb Company Corporation Information Table 108. Bristol-Myers Squibb Company Description and Business Overview Table 109. Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 110. Bristol-Myers Squibb Company Product Table 111. Bristol-Myers Squibb Company Recent Development Table 112. Celgene Corporation Corporation Information Table 113. Celgene Corporation Description and Business Overview Table 114. Celgene Corporation Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 115. Celgene Corporation Product Table 116. Celgene Corporation Recent Development Table 117. Genentech, Inc. Corporation Information Table 118. Genentech, Inc. Description and Business Overview Table 119. Genentech, Inc. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 120. Genentech, Inc. Product Table 121. Genentech, Inc. Recent Development Table 122. Genfit SA Corporation Information Table 123. Genfit SA Description and Business Overview Table 124. Genfit SA Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 125. Genfit SA Product Table 126. Genfit SA Recent Development Table 127. GlaxoSmithKline Plc Corporation Information Table 128. GlaxoSmithKline Plc Description and Business Overview Table 129. GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 130. GlaxoSmithKline Plc Product Table 131. GlaxoSmithKline Plc Recent Development Table 132. Hanmi Pharmaceuticals, Co. Ltd. Corporation Information Table 133. Hanmi Pharmaceuticals, Co. Ltd. Description and Business Overview Table 134. Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 135. Hanmi Pharmaceuticals, Co. Ltd. Product Table 136. Hanmi Pharmaceuticals, Co. Ltd. Recent Development Table 137. Karo Bio AB Corporation Information Table 138. Karo Bio AB Description and Business Overview Table 139. Karo Bio AB Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 140. Karo Bio AB Product Table 141. Karo Bio AB Recent Development Table 142. Lead Pharma Holding B.V. Corporation Information Table 143. Lead Pharma Holding B.V. Description and Business Overview Table 144. Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 145. Lead Pharma Holding B.V. Product Table 146. Lead Pharma Holding B.V. Recent Development Table 147. Nuevolution AB Corporation Information Table 148. Nuevolution AB Description and Business Overview Table 149. Nuevolution AB Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 150. Nuevolution AB Product Table 151. Nuevolution AB Recent Development Table 152. Phenex Pharmaceuticals AG Corporation Information Table 153. Phenex Pharmaceuticals AG Description and Business Overview Table 154. Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 155. Phenex Pharmaceuticals AG Product Table 156. Phenex Pharmaceuticals AG Recent Development Table 157. Reata Pharmaceuticals, Inc. Corporation Information Table 158. Reata Pharmaceuticals, Inc. Description and Business Overview Table 159. Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 160. Reata Pharmaceuticals, Inc. Product Table 161. Reata Pharmaceuticals, Inc. Recent Development Table 162. Teijin Pharma Limited Corporation Information Table 163. Teijin Pharma Limited Description and Business Overview Table 164. Teijin Pharma Limited Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 165. Teijin Pharma Limited Product Table 166. Teijin Pharma Limited Recent Development Table 167. Visionary Pharmaceuticals, Inc. Corporation Information Table 168. Visionary Pharmaceuticals, Inc. Description and Business Overview Table 169. Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 170. Visionary Pharmaceuticals, Inc. Product Table 171. Visionary Pharmaceuticals, Inc. Recent Development Table 172. Vitae Pharmaceuticals, Inc. Corporation Information Table 173. Vitae Pharmaceuticals, Inc. Description and Business Overview Table 174. Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 175. Vitae Pharmaceuticals, Inc. Product Table 176. Vitae Pharmaceuticals, Inc. Recent Development Table 177. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 178. Key Challenges Table 179. Market Risks Table 180. Main Points Interviewed from Key Nuclear Receptor ROR-Gamma Players Table 181. Nuclear Receptor ROR-Gamma Customers List Table 182. Nuclear Receptor ROR-Gamma Distributors List Table 183. Research Programs/Design for This Report Table 184. Key Data Information from Secondary Sources Table 185. Key Data Information from Primary Sources List of Figures Figure 1. Nuclear Receptor ROR-Gamma Product Picture Figure 2. Global Nuclear Receptor ROR-Gamma Sales Market Share by Type in 2020 & 2026 Figure 3. VPR-66 Product Picture Figure 4. INV-17 Product Picture Figure 5. GSK-2981278 Product Picture Figure 6. BBI-6000 Product Picture Figure 7. Others Product Picture Figure 8. Global Nuclear Receptor ROR-Gamma Sales Market Share by Application in 2020 & 2026 Figure 9. Hospital Figure 10. Clinic Figure 11. Others Figure 12. Nuclear Receptor ROR-Gamma Report Years Considered Figure 13. Global Nuclear Receptor ROR-Gamma Market Size 2015-2026 (US$ Million) Figure 14. Global Nuclear Receptor ROR-Gamma Sales 2015-2026 (K Pcs) Figure 15. Global Nuclear Receptor ROR-Gamma Market Size Market Share by Region: 2020 Versus 2026 Figure 16. Global Nuclear Receptor ROR-Gamma Sales Market Share by Region (2015-2020) Figure 17. Global Nuclear Receptor ROR-Gamma Sales Market Share by Region in 2019 Figure 18. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Region (2015-2020) Figure 19. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Region in 2019 Figure 20. Global Nuclear Receptor ROR-Gamma Sales Share by Manufacturer in 2019 Figure 21. The Top 10 and 5 Players Market Share by Nuclear Receptor ROR-Gamma Revenue in 2019 Figure 22. Nuclear Receptor ROR-Gamma Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 23. Global Nuclear Receptor ROR-Gamma Sales Market Share by Type (2015-2020) Figure 24. Global Nuclear Receptor ROR-Gamma Sales Market Share by Type in 2019 Figure 25. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Type (2015-2020) Figure 26. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Type in 2019 Figure 27. Global Nuclear Receptor ROR-Gamma Market Share by Price Range (2015-2020) Figure 28. Global Nuclear Receptor ROR-Gamma Sales Market Share by Application (2015-2020) Figure 29. Global Nuclear Receptor ROR-Gamma Sales Market Share by Application in 2019 Figure 30. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Application (2015-2020) Figure 31. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Application in 2019 Figure 32. United States Nuclear Receptor ROR-Gamma Sales Growth Rate 2015-2026 (K Pcs) Figure 33. United States Nuclear Receptor ROR-Gamma Revenue Growth Rate 2015-2026 (US$ Million) Figure 34. United States Nuclear Receptor ROR-Gamma Market Share in Global Market 2015-2026 Figure 35. United States 5 and 10 Largest Nuclear Receptor ROR-Gamma Players Market Share by Revenue in Nuclear Receptor ROR-Gamma in 2019 Figure 36. United States Nuclear Receptor ROR-Gamma Revenue Share by Type (2015-2020) Figure 37. United States Nuclear Receptor ROR-Gamma Revenue Growth Rate by Type in 2015 & 2019 Figure 38. United States Nuclear Receptor ROR-Gamma Revenue Share by Application (2015-2020) Figure 39. United States Nuclear Receptor ROR-Gamma Revenue Growth Rate by Application in 2015 & 2019 Figure 40. North America Nuclear Receptor ROR-Gamma Sales Growth Rate 2015-2020 (K Pcs) Figure 41. North America Nuclear Receptor ROR-Gamma Revenue Growth Rate 2015-2020 (US$ Million) Figure 42. North America Nuclear Receptor ROR-Gamma Sales Market Share by Country in 2019 Figure 43. North America Nuclear Receptor ROR-Gamma Revenue Market Share by Country in 2019 Figure 44. U.S. Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs) Figure 45. U.S. Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. Canada Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs) Figure 47. Canada Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. Europe Nuclear Receptor ROR-Gamma Sales Growth Rate 2015-2020 (K Pcs) Figure 49. Europe Nuclear Receptor ROR-Gamma Revenue Growth Rate 2015-2020 (US$ Million) Figure 50. Europe Nuclear Receptor ROR-Gamma Sales Market Share by Country in 2019 Figure 51. Europe Nuclear Receptor ROR-Gamma Revenue Market Share by Country in 2019 Figure 52. Germany Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs) Figure 53. Germany Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. France Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs) Figure 55. France Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. U.K. Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs) Figure 57. U.K. Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Italy Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs) Figure 59. Italy Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Russia Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs) Figure 61. Russia Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Asia Pacific Nuclear Receptor ROR-Gamma Sales Growth Rate 2015-2020 (K Pcs) Figure 63. Asia Pacific Nuclear Receptor ROR-Gamma Revenue Growth Rate 2015-2020 (US$ Million) Figure 64. Asia Pacific Nuclear Receptor ROR-Gamma Sales Market Share by Region in 2019 Figure 65. Asia Pacific Nuclear Receptor ROR-Gamma Revenue Market Share by Region in 2019 Figure 66. China Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs) Figure 67. China Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Japan Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs) Figure 69. Japan Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. South Korea Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs) Figure 71. South Korea Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. India Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs) Figure 73. India Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Australia Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs) Figure 75. Australia Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Taiwan Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs) Figure 77. Taiwan Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Indonesia Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs) Figure 79. Indonesia Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Thailand Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs) Figure 81. Thailand Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million) Figure 82. Malaysia Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs) Figure 83. Malaysia Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million) Figure 84. Philippines Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs) Figure 85. Philippines Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million) Figure 86. Vietnam Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs) Figure 87. Vietnam Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million) Figure 88. Latin America Nuclear Receptor ROR-Gamma Sales Growth Rate 2015-2020 (K Pcs) Figure 89. Latin America Nuclear Receptor ROR-Gamma Revenue Growth Rate 2015-2020 (US$ Million) Figure 90. Latin America Nuclear Receptor ROR-Gamma Sales Market Share by Country in 2019 Figure 91. Latin America Nuclear Receptor ROR-Gamma Revenue Market Share by Country in 2019 Figure 92. Mexico Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs) Figure 93. Mexico Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million) Figure 94. Brazil Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs) Figure 95. Brazil Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million) Figure 96. Argentina Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs) Figure 97. Argentina Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million) Figure 98. Middle East and Africa Nuclear Receptor ROR-Gamma Sales Growth Rate 2015-2020 (K Pcs) Figure 99. Middle East and Africa Nuclear Receptor ROR-Gamma Revenue Growth Rate 2015-2020 (US$ Million) Figure 100. Middle East and Africa Nuclear Receptor ROR-Gamma Sales Market Share by Country in 2019 Figure 101. Middle East and Africa Nuclear Receptor ROR-Gamma Revenue Market Share by Country in 2019 Figure 102. Turkey Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs) Figure 103. Turkey Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million) Figure 104. Saudi Arabia Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs) Figure 105. Saudi Arabia Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million) Figure 106. U.A.E Nuclear Receptor ROR-Gamma Sales Growth Rate (2015-2020) (K Pcs) Figure 107. U.A.E Nuclear Receptor ROR-Gamma Revenue Growth Rate (2015-2020) (US$ Million) Figure 108. Porter's Five Forces Analysis Figure 109. Nuclear Receptor ROR-Gamma Value Chain Figure 110. Channels of Distribution Figure 111. Distributors Profiles Figure 112. Bottom-up and Top-down Approaches for This Report Figure 113. Data Triangulation Figure 114. Key Executives Interviewed

4SC AG Advinus Therapeutics Ltd. Arrien Pharmaceuticals, LLC Aurigene Discovery Technologies Limited Biogen, Inc. Brickell Biotech, Inc. Bristol-Myers Squibb Company Celgene Corporation Genentech, Inc. Genfit SA GlaxoSmithKline Plc Hanmi Pharmaceuticals, Co. Ltd. Karo Bio AB Lead Pharma Holding B.V. Nuevolution AB Phenex Pharmaceuticals AG Reata Pharmaceuticals, Inc. Teijin Pharma Limited Visionary Pharmaceuticals, Inc. Vitae Pharmaceuticals, Inc.